SCHEMBL7712448

SCHEMBL7712448

Nc1ncc(Oc2ccc(Cl)cc2)c(N2CCN(c3ccccn3)CC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 6/20 0.46
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
TSHR P16473 2/20 0.46
HSD17B10 Q99714 2/20 0.46
MAPK1 P28482 3/20 0.45
USP2 O75604 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAPT P10636 3/20 0.44
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44
HSP90AA1 P07900 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7712369 0.85 DHFR (0.50) KMT2AKDM4EALDH1A1SMN1; SMN2TSHR
SCHEMBL7708416 0.82 HRH4 (0.55) HRH4
SCHEMBL7708471 0.82 DHFR (0.41) MEN1KMT2ASMN1; SMN2HRH4HTT
SCHEMBL7708599 0.81 DRD4 (0.48) MEN1KMT2AKDM4EALDH1A1LMNA
SCHEMBL7714137 0.80 LTA4H (0.51) HRH4
SCHEMBL7714247 0.80 MEN1 (0.53) MEN1KMT2ANPSR1HTT
SCHEMBL7714398 0.80 KDM4E (0.43) MEN1KMT2AKDM4EALDH1A1LMNA
SCHEMBL7714275 0.79 POLB (0.48) KMT2AKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL7714727 0.79 ALDH1A1 (0.51) MEN1KMT2AALDH1A1LMNAHSD17B10
SCHEMBL7716713 0.78 DHFR (0.39) MEN1KMT2AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed